Welcome to our dedicated page for C3.ai SEC filings (Ticker: AI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
C3.ai, Inc. filings document the regulatory record of an enterprise AI application software company listed on the NYSE. Recent 8-K disclosures cover operating and financial results, material events, governance matters, stockholder voting outcomes, and exhibits tied to corporate actions.
The company’s filings also describe board composition, director compensation, the 2025 Inducement Plan for equity-based employment awards, Class A common stock reserved for plan issuance, and annual meeting matters such as director elections, executive compensation votes, and auditor ratification. Other filings address securities litigation disclosures involving statements in the company’s IPO registration statement and related Exchange Act and Securities Act claims.
C3.ai, Inc. executive chairman, director and 10% owner Thomas M. Siebel reported multiple equity transactions in December 2025. On 12/11/2025, 44,767 restricted stock units vested into Class A common stock and he received a new grant of 722,362 RSUs, which vest 33% on December 11, 2026 and then quarterly. On 12/12/2025, 23,000 shares were sold at a weighted-average price of $15.94 to cover tax withholding obligations linked to the RSU vesting.
On the same date, he also received a stock option to buy 1,133,474 Class A shares at an exercise price of $17.512 per share, vesting in three equal annual installments starting December 11, 2026 and expiring on December 10, 2035. Following these transactions, he reports 722,362 shares held directly and additional indirect holdings through family trusts and investment entities.
C3.ai, Inc. reported weaker results for the quarter ended October 31, 2025. Total revenue fell to $75.1 million from $94.3 million a year earlier, driven by lower subscription revenue and a sharp drop in professional services. For the first six months, revenue declined to $145.4 million from $181.6 million.
Operating costs continued to rise, especially in sales and marketing, research and development, and general and administrative expenses. As a result, the quarterly net loss widened to $104.7 million from $66.0 million, and the six‑month net loss increased to $221.4 million from $128.8 million. Stock-based compensation was significant at $68.9 million for the quarter and $133.6 million year-to-date.
Cash, cash equivalents and marketable securities remained sizable, with marketable securities of $571.8 million and cash and cash equivalents of $103.2 million as of October 31, 2025. However, the company used $80.0 million of cash in operating activities over six months. Remaining performance obligations totaled $232.5 million, with $136.0 million expected to be recognized as revenue over the next 12 months.
C3.ai, Inc. insider Thomas M. Siebel, Executive Chairman, director and 10% owner, reported several equity transactions in Class A common stock. On 12/01/2025, 32,736 shares were acquired upon the vesting and settlement of restricted stock units, with a matching reduction in RSUs reported as an exercise (code M). On 12/02/2025, 17,000 shares were sold (code S) at a weighted-average price of $14.21, with the company’s explanation stating these sales were automatically made to cover tax withholding on the RSU vesting. On 12/03/2025, 15,736 shares were transferred as gifts (code G) from direct ownership to indirect ownership at zero price. Following these transactions, Siebel reports direct ownership of Class A common stock and substantial indirect holdings through multiple entities and trusts, as well as 130,946 RSUs that remain outstanding and unexercised.
C3.ai, Inc. reported that it has released its financial results for the fiscal second quarter ended October 31, 2025 through a press release. The company’s Class A common stock continues to trade on the New York Stock Exchange under the symbol AI. The press release is provided as an exhibit and is referenced as part of this disclosure.
The company also notes that the information about these results, including the press release, is being furnished rather than filed under securities law, which affects how it is treated for certain liability purposes and for incorporation into other regulatory documents.
C3.ai, Inc. (AI) reported the initial holdings of a director on a Form 3. The director beneficially owns 300,000 shares of Class A Common Stock in direct form. This total includes 249,807 restricted stock units (RSUs) that were unvested as of the stated date. Each RSU represents a right to receive one share of Class A Common Stock on a one-for-one basis when it settles.
C3.ai, Inc. (AI) disclosed updated ownership in an Amendment No. 5 to Schedule 13G. Thomas M. Siebel reported beneficial ownership of 27,368,188 Class A shares, representing 17.2% of the class as of the stated event date.
Related reporting persons and their respective holdings include: The Siebel Living Trust with 4,582,922 shares (3.3%), Siebel Asset Management, L.P. with 170,294 (0.1%), Siebel Asset Management III, L.P. with 72,695 (0.1%), First Virtual Holdings, LLC with 509,216 (0.4%), and The Siebel 2011 Irrevocable Children's Trust with 1,237,115 (0.9%).
C3.ai (AI): Susquehanna-affiliated broker-dealers filed a Schedule 13G reporting a passive stake. G1 Execution Services, SIG Brokerage, Susquehanna Investment Group, and Susquehanna Securities collectively reported beneficial ownership of 7,128,448 Class A shares, representing 5.3% of the class, with a Date of Event of 09/30/2025. The group reports shared voting and dispositive power over these shares and indicates they may be deemed a group while each disclaims beneficial ownership of shares owned by the others.
The filing notes options are included within certain positions: SIG Brokerage’s reported shares consist of options; Susquehanna Investment Group includes options to buy 286,200 shares; and Susquehanna Securities includes options to buy 3,501,000 shares. C3.ai had 134,349,704 shares outstanding as of August 28, 2025, according to its Form 10-Q. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
C3.ai, Inc. expanded its Board from eleven to twelve members and elected Mike Clayville as a Class II director, effective immediately. He will serve until the Company’s 2028 Annual Meeting of Stockholders and until a successor is elected and qualified or earlier departure.
Consistent with the Company’s director compensation, Mr. Clayville will receive stock options with a grant date fair value of $350,000, with an exercise price equal to the fair value on the grant date. The award vests over two years, with 12.5% of the shares vesting quarterly after grant, contingent on his continued service as a non‑employee director and attendance at regularly scheduled Board meetings each fiscal quarter. The options vest in full upon a change in control, subject to continued service until closing. He will not receive cash compensation and has no related‑party transactions requiring disclosure.
The Company issued a press release on November 13, 2025, attached as Exhibit 99.1.
C3.ai (AI) reported an insider transaction by an Executive Chairman who is also a Director and 10% Owner. On 11/11/2025, the reporting person sold 543,706 shares of Class A Common Stock under a previously established Rule 10b5-1 trading plan dated September 20, 2024.
The reported weighted-average price was $15.24, with individual trades executed between $14.91 and $15.59. Following the sale, beneficial ownership includes 1,437,174 shares held indirectly by a trust, plus additional indirect holdings of 9,216, 170,294, 72,695, and 1,237,115 shares through related entities, as noted in the footnotes.
C3.ai (AI) filed a Form 144 notice for a proposed sale of 1,386,127 shares of Class A Common Stock. The filing lists an aggregate market value of $21,484,968, with J.P. Morgan Securities LLC as broker and an approximate sale date of 11/11/2025 on the NYSE.
The shares to be sold include 537,634 acquired via stock option exercise on 08/30/2024 (cash) and 848,493 identified as founder shares acquired on 02/12/2020. Shares outstanding were 134,349,704 as of the filing’s reference table; this is a baseline figure, not the amount being sold.
Recent three-month sales reported for related accounts include examples such as 92,000 shares for $1,502,250 on 09/12/2025 and 554,802 shares for $10,441,147 on 10/14/2025. Form 144 is a notice of intent and does not itself complete a sale.